# A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)

> **NCT01844804** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 146 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** PF-06438179
- **BIOLOGICAL:** Remicade
- **BIOLOGICAL:** Remicade

## Key facts

- **NCT ID:** NCT01844804
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2014-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01844804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01844804, "A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01844804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*